Clinical Trials Directory

Trials / Completed

CompletedNCT06676995

Effects of Transcranial Pulse Stimulation in Parkinson's Disease

Parkinson's Disease: Overall Symptoms Improvement With Transcranial Pulse Stimulation (TPS)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Spaulding Rehabilitation Hospital · Academic / Other
Sex
All
Age
40 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The investigators are studying if Transcranial Pulse Stimulation (TPS) can improve various symptoms, including movement problems, thinking abilities, mood, fatigue, freezing while walking, voice quality, and issues with smell and taste. Previous research suggests TPS might help in Alzheimer's disease and could be helpful for Parkinson's as well. Investigators will check if TPS is safe, practical, and if it makes a noticeable difference in these symptoms compared to before the treatment.

Conditions

Interventions

TypeNameDescription
DEVICETranscranial Pulse Stimulation (TPS)Transcranial Pulse Stimulation (TPS) is a non invasive brain stimulation technology that applies repetitive single high-pressure ultrashort shockwave pulses within the ultrasound frequency range to stimulate the brain. Subjects will receive 12 TPS sessions conducted three times weekly, for about 40 to 50 minutes/day, over four consecutive weeks.

Timeline

Start date
2024-12-31
Primary completion
2025-06-27
Completion
2025-07-30
First posted
2024-11-06
Last updated
2025-12-05

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06676995. Inclusion in this directory is not an endorsement.